Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer-Reference-Cited by-同舟云学术

Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer

Published:2007-10 Issue:1 Volume:58 Page:116-122
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Park Sarah,Ahn Myung Ju,Ahn Jin Seok,Lee Jeeyun,Hong Yong Sang,Park Byeong-Bae,Lee Sang Chul,Hwang In Gyu,Park Joon Oh,Lim Hoyeong,Kang Won Ki,Park Keunchil

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference39 articles.

1. Oat cell lung cancer;Watson;Cancer,1962

2. Alkylating agents in bronchogenic carcinoma;Green;Am J Med,1969

3. VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer;Evans;Cancer,1984

4. First-line therapy with VP-16 and cisplatin for small-cell lung cancer;Evans;Semin Oncol,1986

5. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real World Analysis of Small Cell Lung Cancer Patients: Prognostic Factors and Treatment Outcomes;Current Oncology;2021-01-08

2. Irinotecan monotherapy as third- or further-line treatment for patients with small cell lung cancer;Tumori Journal;2020-11-25

3. Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients;Journal of Thoracic Disease;2020-03

4. Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study;British Journal of Cancer;2019-09-16

5. Apatinib for chemotherapy-refractory extensive-stage SCLC: a retrospective study;Cancer Chemotherapy and Pharmacology;2019-04-01